A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5

por Xia, Lin, Xian, Yangfei, Wang, Daning, Chen, Yuanzhi, Huang, Xiaofen, Bi, Xingjian, Yu, Hai, Fu, Zheng, Liu, Xinlin, Li, Shaowei, An, Zhiqiang, Luo, Wenxin, Zhao, Qinjian, Xia, Ningshao
Publicado 2016

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody

por Wang, Daning, Li, Zhihai, Xiao, Jieqiong, Wang, Junqi, Zhang, Li, Liu, Yajing, Fan, Fei, Xin, Lu, Wei, Minxi, Kong, Zhibo, Yu, Hai, Gu, Ying, Zhang, Jun, Li, Shaowei, Xia, Ningshao
Publicado 2015

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

por Liu, Xinlin, Chen, Jie, Wang, Zhiping, Wang, Daning, He, Maozhou, Qian, Ciying, Song, Shuo, Chi, Xin, Kong, Zhibo, Zheng, Qingbing, Wang, Yingbin, Yu, Hai, Zhao, Qinjian, Zhang, Jun, Li, Shaowei, Gu, Ying, Xia, Ningshao
Publicado 2019

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus

por Li, Zhihai, Wang, Daning, Gu, Ying, Song, Shuo, He, Maozhou, Shi, Jingjie, Liu, Xinlin, Wei, Shuangping, Li, Jinjin, Yu, Hai, Zheng, Qingbing, Yan, Xiaodong, Baker, Timothy S., Zhang, Jun, McLellan, Jason S., Li, Shaowei, Xia, Ningshao
Publicado 2017

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro

por Wei, Minxi, Wang, Daning, Li, Zhihai, Song, Shuo, Kong, Xianglin, Mo, Xiaobing, Yang, Yurou, He, Maozhou, Li, Zhongyi, Huang, Bo, Lin, Zhijie, Pan, Huirong, Zheng, Qingbing, Yu, Hai, Gu, Ying, Zhang, Jun, Li, Shaowei, Xia, Ningshao
Publicado 2018

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity

por Li, Zhihai, Song, Shuo, He, Maozhou, Wang, Daning, Shi, Jingjie, Liu, Xinlin, Li, Yunbing, Chi, Xin, Wei, Shuangping, Yang, Yurou, Wang, Zhiping, Li, Jinjin, Qian, Huilian, Yu, Hai, Zheng, Qingbing, Yan, Xiaodong, Zhao, Qinjian, Zhang, Jun, Gu, Ying, Li, Shaowei, Xia, Ningshao
Publicado 2018

Viral neutralization by antibody-imposed physical disruption

por Zheng, Qingbing, Jiang, Jie, He, Maozhou, Zheng, Zizheng, Yu, Hai, Li, Tingting, Xue, Wenhui, Tang, Zimin, Ying, Dong, Li, Zekai, Song, Shuo, Liu, Xinlin, Wang, Kaihang, Zhang, Zhiqing, Wang, Daning, Wang, Yingbin, Yan, Xiaodong, Zhao, Qinjian, Zhang, Jun, Gu, Ying, Li, Shaowei, Xia, Ningshao
Publicado 2019

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

por Wang, Daning, Liu, Xinlin, Wei, Minxi, Qian, Ciying, Song, Shuo, Chen, Jie, Wang, Zhiping, Xu, Qin, Yang, Yurou, He, Maozhou, Chi, Xin, Huang, Shiwen, Li, Tingting, Kong, Zhibo, Zheng, Qingbing, Yu, Hai, Wang, Yingbin, Zhao, Qinjian, Zhang, Jun, Xia, Ningshao, Gu, Ying, Li, Shaowei
Publicado 2020

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

por Qian, Ciying, Yang, Yurou, Xu, Qin, Wang, Zhiping, Chen, Jie, Chi, Xin, Yu, Miao, Gao, Fei, Xu, Yujie, Lu, Yihan, Sun, Hui, Shen, Jingjia, Wang, Daning, Zhou, Lizhi, Li, Tingting, Wang, Yingbin, Zheng, Qingbing, Yu, Hai, Zhang, Jun, Gu, Ying, Xia, Ningshao, Li, Shaowei
Publicado 2022